| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 626,439 | 631,900 | 629,369 | 640,508 |
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 187,179 | 190,537 | 196,829 | 179,745 |
| Advertising and marketing | 167,985 | 167,547 | 168,185 | 177,462 |
| Sales | 48,209 | 49,951 | 48,693 | 47,465 |
| Technology and development | 67,572 | 68,784 | 69,958 | 72,383 |
| General and administrative | 102,581 | 108,114 | 112,774 | 114,245 |
| Goodwill impairments | 12,625 | 0 | 59,138 | - |
| Acquisition, integration, and transformation costs | 1,931 | 2,658 | 2,188 | 457 |
| Restructuring costs | 1,950 | 5,692 | 4,347 | 3,580 |
| Amortization of intangible assets | 85,757 | 88,664 | 84,304 | 86,906 |
| Depreciation of property and equipment | 2,612 | 4,338 | 3,564 | 2,666 |
| Total costs and expenses | 678,401 | 686,285 | 749,980 | 684,909 |
| Loss from operations | -51,962 | -54,385 | -120,611 | -44,401 |
| Interest income | 7,081 | 10,064 | 12,674 | 15,326 |
| Interest expense | 4,526 | 4,473 | 5,765 | 5,660 |
| Other expense (income), net | -815 | 8,371 | 2,435 | 2,239 |
| Loss before provision for income taxes | -50,222 | -40,423 | -111,267 | -32,496 |
| Provision for income taxes | -715 | -7,763 | -18,255 | 780 |
| Net loss | -49,507 | -32,660 | -93,012 | -33,276 |
| Currency translation adjustment | 791 | 1,847 | 1,143 | 1,860 |
| Comprehensive loss | -48,716 | -30,813 | -91,869 | -31,416 |
| Net loss per share, basic (in dollars per share) | -0.28 | -0.19 | -0.53 | -0.19 |
| Net loss per share, diluted (in dollars per share) | -0.28 | -0.19 | -0.53 | -0.19 |
| Weighted-average shares used to compute basic net loss per share (in shares) | 176,934,781 | 175,917,380 | 174,154,128 | 171,496,282 |
| Weighted-average shares used to compute diluted net loss per share (in shares) | 176,934,781 | 175,917,380 | 174,154,128 | 171,496,282 |
Teladoc Health, Inc. (TDOC)
Teladoc Health, Inc. (TDOC)